Société Française d'Immuno-Thérapie du Cancer Follow 261 299

FITC_cancer

#Concours "Trucs et Astuces au Labo": vous êtes jeune #chercheur et avez réussi à résoudre une situation difficile au labo? montrez-nous comment en #vidéo! un prix de 200€ sera attribué à la meilleure vidéo!
pour en savoir plus: https://t.co/x2VhsdOL6y

Reply on Twitter 1530468409825165312 Retweet on Twitter 1530468409825165312 7 Like on Twitter 1530468409825165312 2 Twitter 1530468409825165312

🗓 Evenement
L’AFSOS organise comme chaque année son congrès national. Cette 13ème édition se déroulera les 7 et 8 octobre 2021 au Palais Brongniart à Paris et certaines sessions seront retransmises en live!

Plus d'infos: https://t.co/mdNZizQlAN

Reply on Twitter 1530454332436537345 Retweet on Twitter 1530454332436537345 0 Like on Twitter 1530454332436537345 0 Twitter 1530454332436537345

Les #inscriptions à la journée annuelle de la FITC sont ouvertes!
Comme chaque année, nous prenons en charge les frais de voyage et d'hébergement de TOUS les jeunes chercheurs qui présentent leurs travaux!!
https://t.co/w32oB5lwyt

Reply on Twitter 1529503329176387586 Retweet on Twitter 1529503329176387586 1 Like on Twitter 1529503329176387586 1 Twitter 1529503329176387586

🗓️Event: The ITOC9 conference will be held in Munich on September 22-24!
More information here: https://t.co/OUa2mrQmGX

Reply on Twitter 1527559925743984643 Retweet on Twitter 1527559925743984643 0 Like on Twitter 1527559925743984643 3 Twitter 1527559925743984643

🗓La 5ème édition du symposium iTOX dédié aux effets indésirables induits par les immunothérapies en cancérologie se déroulera les jeudi 19 et vendredi 20 mai à la Cité Internationale Universitaire de Paris.
Inscriptions: https://t.co/M5fwr7krAC

Reply on Twitter 1523590256691359744 Retweet on Twitter 1523590256691359744 2 Like on Twitter 1523590256691359744 8 Twitter 1523590256691359744

#jobadvert The CISTAR Laboratory " Cancer Immune Surveillance and Therapeutic tARgeting" is looking for a computational biologist in single cell OMICS applied to immune-oncology
more info: https://t.co/TdZzNdIiHf

Reply on Twitter 1522209428568649735 Retweet on Twitter 1522209428568649735 1 Like on Twitter 1522209428568649735 1 Twitter 1522209428568649735

#Workshop FITC and @CarnotCALYM : voici le programme final! https://t.co/oPHcDMa4wn

Il vous pouvez encore vous inscrire et il reste encore quelques jours pour soumettre un abstract !

inscriptions: https://t.co/kKcJYNYLM0

Reply on Twitter 1521854386032553984 Retweet on Twitter 1521854386032553984 1 Like on Twitter 1521854386032553984 3 Twitter 1521854386032553984

#publication L’équipe du Pr Aurélien Marabelle vient de publier un article dans le Journal of Clinical Investigations décrivant les mécanismes d’échappement immunitaire des cancers de vessie traités par BCG.
https://t.co/hjevL2dgXv

Reply on Twitter 1521760129338814466 Retweet on Twitter 1521760129338814466 0 Like on Twitter 1521760129338814466 3 Twitter 1521760129338814466

Date limite repoussée:
Vous pouvez encore soumettre un abstract pour notre workshop du 18 mai!
C'est par ici
https://t.co/iy6xhZWuoM

Reply on Twitter 1521152250823036928 Retweet on Twitter 1521152250823036928 0 Like on Twitter 1521152250823036928 1 Twitter 1521152250823036928

Bonne #nouvelle: l'EMA donn son autorisation pour l'utilisation du pembrolizumab sur les biomarqueurs MSI-H/dMMR dans les indications CRC, Gastrique, Intestin grêle, cholangiocarcinome, et endomètre.
A quand l'autorisation pour l'ensemble des cancers MSI?

Reply on Twitter 1521150983564406784 Retweet on Twitter 1521150983564406784 1 Like on Twitter 1521150983564406784 3 Twitter 1521150983564406784

PROMOTING THE DEVELOPMENT AND


ACCESS TO IMMUNOTHERAPIES IN FRANCE

The FITC represents oncologists and research scientists involved in understanding tumor immunity and developing cancer immunotherapies in collaboration with French academic societies (SFI, SFC, LySA etc.).

Our objective is to bridge national institutions (HAS, CEPS, INCa, etc. ) and governing bodies (Senate, National assembly) in order to improve the implementation of immunotherapies in France and to increase funding of research in cancer immunology.

For complete transparency in access to immunotherapy, you will discover soon the list of cancers for which treatment by immunotherapy is covered by social healthcare in France.

Discover soon the list of clinical trials in cancer immunotherapy currently open in France.

INTERNATIONAL COLLABORATION

AND NETWORKING

The FITC is part of the World Immunotherapy Council (WIC) – a group of societies across the globe, dedicated to the development of immunotherapy and immuno-oncology.

Explore

OUR ANNUAL MEETING

The French Society of Immunotherapy’s (FITC) annual meeting brings together several stakeholders – scientists, clinicians, pharmacists, ethic committees, regulatory agencies – around a high caliber scientific event centered on advances in the field of cancer immunology and immunotherapy. We also organize scientific updates and discussions over data presented at main cancer conferences such as AACR, ASCO, ASH, EHA, ESMO and SITC.

In particular, young scientists in France are offered a chance to present their work in clinical, fundamental and translational immuno-oncology.

Explore

PATIENT AND FAMILY EDUCATION

The FITC considers it a priority to educate patients and their families about the immunology of cancer and the therapy they receive. A freely available document introduces patients to the basic mechanisms of immunology, treatment by immunotherapy and the management of potential side-effects. We aim to constantly supplement these guidelines as new strategies are developed.

DISCOVER

PROMOTING RESEARCH

The FITC has created the first directory of French clinical and basic science research teams working towards understanding tumor immunology and immunotherapy. The expertise of each team is described to increase collaboration between clinicians, scientists and industrial partners.

An FITC scientific council provides expert advice to evaluate documents required by French institutions and partners.

A collaboration initiated between French research groups aims to build an immunology Atlas of human tumors.

IMPROVE TRAINING

The FITC has catalogued French training programs in cancer immunology and immunotherapy. FITC-endorsed courses can be found here.

Courses specific to the FITC are also available in the form of short videos on specific themes (research and clinic) and are associated with a discussion forum.

A training workshop is offered each year during the annual meeting.

TRAININGS

BRINGING PATIENTS TOGETHER

AROUND IMMUNOTHERAPY

We believe that patients should be able to influence decisions pertaining to their access to immunotherapy. The FITC unites patient support groups for different cancers around immunotherapy.

We aim to provide information and explanations regarding French regulatory constraints to enable patient groups to comprehend the processes and ensure their voice is heard.

Explore

become a member

To become a member of the FITC, register here.

JOIN

FITC NEWS

To subscribe to the FITC newsletter, register here.

En poursuivant votre navigation, vous acceptez l'utilisation de cookies pour pouvoir utiliser les fonctionnalités du site. Pour en savoir plus sur notre politique en matière de cookies et sur la manière de les définir.
Politique de confidentialité

Accepter les paramètresTout refuserPlus d'informations